ANDREW WIESE to Male
This is a "connection" page, showing publications ANDREW WIESE has written about Male.
Connection Strength
0.254
-
Performance of Phenotype Algorithms for the Identification of Opioid-Exposed Infants. Hosp Pediatr. 2024 06 01; 14(6):438-447.
Score: 0.035
-
Long-acting Opioid Use and the Risk of Serious Infections: A Retrospective Cohort Study. Clin Infect Dis. 2019 05 17; 68(11):1862-1869.
Score: 0.025
-
Performance of a computable phenotype for identification of patients with diabetes within PCORnet: The Patient-Centered Clinical Research Network. Pharmacoepidemiol Drug Saf. 2019 05; 28(5):632-639.
Score: 0.024
-
Validation of discharge diagnosis codes to identify serious infections among middle age and older adults. BMJ Open. 2018 06 19; 8(6):e020857.
Score: 0.023
-
Statewide Academic Performance of High School Students With Sickle Cell Disease. Pediatr Blood Cancer. 2025 Oct; 72(10):e31947.
Score: 0.010
-
Transdiagnostic links of reward processing in obsessive-compulsive disorder and depression. J Affect Disord. 2025 Dec 15; 391:119886.
Score: 0.010
-
Osteogenesis imperfecta and the family: A qualitative analysis of the experiences of family and caregivers. Fam Syst Health. 2025 Sep; 43(3):482-499.
Score: 0.010
-
Benchmarking empirical severity for the Yale-Brown Obsessive Compulsive Scale-Second Edition. J Affect Disord. 2025 Dec 01; 390:119719.
Score: 0.010
-
Psychometric properties of the Spanish Yale-Brown Obsessive-Compulsive Scale - Second Edition. Psychiatry Res. 2025 Jun; 348:116456.
Score: 0.009
-
Adapting a Risk Prediction Tool for Neonatal Opioid Withdrawal Syndrome. Pediatrics. 2025 Apr 01; 155(4).
Score: 0.009
-
Comparative effectiveness of buprenorphine adherence with telemedicine vs. in-person for rural and urban patients. J Am Pharm Assoc (2003). 2025 Mar-Apr; 65(2):102318.
Score: 0.009
-
Psychometric Properties of the Yale-Brown Obsessive Compulsive Scale-II Self-Report. J Psychiatr Pract. 2024 Nov 01; 30(6):421-427.
Score: 0.009
-
Sex and Gender Variables in Data Set Creation and Data Cleaning for Inclusive and Accurate Reproductive Health Research and Quality Improvement. J Midwifery Womens Health. 2025 Jan-Feb; 70(1):131-136.
Score: 0.009
-
Concurrent Validity of the Anxiety Disorders Section of the Anxiety Disorder Interview Schedule- Autism Spectrum Addendum (ADIS-ASA) in Autistic Youth. J Autism Dev Disord. 2025 Nov; 55(11):4057-4067.
Score: 0.009
-
Resilience and coping: a qualitative analysis of cognitive and behavioral factors in adults with osteogenesis Imperfecta. Disabil Rehabil. 2025 Feb; 47(3):709-718.
Score: 0.009
-
Impact of inpatient addiction psychiatry consultation on opioid use disorder outcomes. Am J Addict. 2024 Sep; 33(5):543-550.
Score: 0.009
-
Psychosocial Outcomes of Pain and Pain Management in Adults with Osteogenesis Imperfecta: A Qualitative Study. J Clin Psychol Med Settings. 2024 Sep; 31(3):614-627.
Score: 0.009
-
Maternal Opioid Use Disorder and the Risk of Postneonatal Infant Mortality. JAMA Pediatr. 2023 07 01; 177(7):675-683.
Score: 0.008
-
Long-term ecological assessment of intracranial electrophysiology synchronized to behavioral markers in obsessive-compulsive disorder. Nat Med. 2021 12; 27(12):2154-2164.
Score: 0.007
-
Diabetes medication regimens and patient clinical characteristics in the national patient-centered clinical research network, PCORnet. Pharmacol Res Perspect. 2020 10; 8(5):e00637.
Score: 0.007
-
Fungal infections associated with contaminated methylprednisolone injections. N Engl J Med. 2013 Oct 24; 369(17):1598-609.
Score: 0.004